PubMed · 2001 · 33 citations · 0 references
PharmacyPharmaceuticsPharmacologyBioavailabilityDissolution TestingDrug DeliveryBioavailability AnalysisDrug Release From Dosage FormsDrug Release KineticsFormulation Effects On BioavailabilityFormulation Effects On DissolutionSustained Release FormulationsDissolution Test Method ValidationDrug Release MechanismsPeak Plasma Concentration Changes
In chronopharmacotherapy, circadian changes in disease symptoms are taken into account. Press-coated, time-controlled release tablets containing pseudoephedrine hydrochloride as a model drug have been formulated and the suitability of this highly soluble drug in relation to the new drug delivery system was evaluated. Hydroxypropylmethylcellulose was used in the coat of the tablet to adjust drug release. If such a formulation was administered in the evening it would have maximal effect in the early morning, and would be useful for the treatment of nocturnal symptoms. Two cross-over, single-dose bioavailability studies were carried out on eight healthy volunteers. A dissolution test method was developed to establish level A and level C in vitro/in vivo correlation for four formulations. With a low viscosity grade of polymer, peak concentrations were achieved after five hours. The drug was absorbed much more slowly from tablets containing a high viscosity grade polymer, with a plasma peak at ten hours. For further development of the drug delivery system described, a dissolution test method at pH 7.2 at a rotation speed of 150 min-1 is recommended on the basis of level A in vitro/in vivo correlation.